Zhang C, Guo W, Cheng Y, et al. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China. Mol Genet Genomic Med. 2019;7:e574 10.1002/mgg3.574 30955239

1. INTRODUCTION {#mgg3574-sec-0005}
===============

Personalized medicine (Jain, [2009](#mgg3574-bib-0012){ref-type="ref"}) simply means selection of a best treatment suited for a person on a comprehensive consideration of each patient\'s characteristics. Its scope is more wider, including pharmacogenetics, pharmacogenomics, and so forth. Pharmacogenomics, a crucial foundation for the development of personalized medicine and patient medication management, enables therapy more precisely.

Furthermore, the Pharmacogenomics Knowledge Base (PharmGKB: <http://www.pharmgkb.org>) is an extremely useful resource for explaining the gene--drug--disease relationships, more importantly, supporting personalized medicine projects. Recently, a large number of pharmacogenomics studies focused on genetic variations considered to be involved in response to or metabolism of drugs (Evans & McLeod, [2003](#mgg3574-bib-0007){ref-type="ref"}). These genetic variations also called very important pharmacogenetic (VIP) variants (Peters & McLeod, [2008](#mgg3574-bib-0021){ref-type="ref"}). At present, there were a total of 246 VIP variants located in 66 genes, which have been summarized in the PharmGKB database.

Numerous studies have elucidated that the importance of ethnicity is great in influencing the frequencies of gene variants. There are 56 ethnic minorities in China, including the Blang ethnic group. The Blang nationality has a population of 91,882 (the fifth national census statistics in 2000), most of whom live in Mount Blang, Xiding, Bada, Mengman, and Daluo areas of Menghai County in Xishuangbanna Dai Autonomous Prefecture of Yunnan province of Southwest China. The others distribute in \*\*\*Lincang, Simao, and Baoshan areas (Wang, Hu et al., [2008a](#mgg3574-bib-0026){ref-type="ref"}). The areas they live in are mild climate and rich products. They are mainly engaged in agricultural production, especially tea planting, which is the origin of the famous Pu\'er tea.

This study aims to determine the Blang\'s genotype and allele frequencies distribution of pharmacogenetic variants. And we compare Blang with the 11 HapMap populations and two national minorities to assess the differences in allele frequencies. The results will complement the database information of pharmacogenomics, better understand the Blang nationality, and provide them with more reasonable individualized health management in the future.

2. MATERIALS AND METHODS {#mgg3574-sec-0006}
========================

2.1. Ethical compliance {#mgg3574-sec-0007}
-----------------------

All participants were informed both in writing and verbally to the procedures and purpose of the study and signed informed consent documents. The study protocol was approved by the Clinical Research Ethics Committee of Xizang Minzu University. It is in accordance with the Department of Health and Human Services (DHHS) regulations for human research subject protection.

2.2. Study participants {#mgg3574-sec-0008}
-----------------------

We randomly recruited about 100 unrelated, healthy Blang people from the Yunnan Province of China. Each participant has undergone rigorous screening criteria. None of the subjects had any diseases including self‐reported cancer history and other diseases. Moreover, despite the influence of the Han and Dai people whose economy and culture development are relatively rapid, they still maintain the characteristics of the nation. They can be seen as representatives of the Blang population.

2.3. Variant selection and genotyping {#mgg3574-sec-0009}
-------------------------------------

We chose 80 VIP variants loci located in 47 genes from the PharmGKB database. Genomic DNA was extracted from peripheral blood sample using the GoldMag‐Mini Whole Blood Genomic DNA Purification Kit (GoldMag Ltd. Xi\'an, China) according to the manufacturer\'s protocol. NanoDrop 2000C spectrophotometer (Thermo Scientific, Waltham, MA) was used to measure the DNA concentration. We utilized the Sequenom MassARRAY Assay Design 3.0 Software (San Diego, CA) to design Multiplexed SNP MassEXTEND assays (Gabriel, Ziaugra, & Tabbaa, [2009](#mgg3574-bib-0008){ref-type="ref"}) and genotyped the variants using Sequenom MassARRAY RS1000 (San Diego, CA). Based on the Sequenom Typer 4.0 software (San Diego, CA) used in previous research (He et al., [2015](#mgg3574-bib-0010){ref-type="ref"}; Jin, Aikemu et al., [2015a](#mgg3574-bib-0013){ref-type="ref"}; Jin, Yang et al., [2015b](#mgg3574-bib-0015){ref-type="ref"}; Thomas et al., [2007](#mgg3574-bib-0025){ref-type="ref"}), we completed data management and analyses.

2.4. Statistical analyses {#mgg3574-sec-0010}
-------------------------

We performed χ^2^ tests and Hardy--Weinberg equilibrium (HWE) analysis by the Microsoft Excel (Redmond, WA) and SPSS 19.0 statistical software platform (SPSS, Chicago, IL). The genotype frequencies of 80 variants in the Blang population were separately compared with those of the other populations, including the Chinese Han in Beijing, China (CHB); the Chinese of metropolitan Denver, Colorado, USA (CHD); the Japanese in Tokyo, Japan (JPT); a residents population in Utah with Northern and Western European Ancestry (CEU); the Gujarati Indians in Houston, Texas, USA (GIH); people with Mexican ancestry living in Los Angeles, California, USA (MEX); the Tuscan people of Italy (TSI); a population of African ancestry in the southwestern USA (ASW); the Luhya people in Webuye, Kenya (LWK); the Maasai people in Kinyawa, Kenya (MKK); and the Yoruba in Ibadan, Nigeria (YRI). All p values of less than 0.05 obtained in this study were two‐sided and Bonferroni\'s multiple tests were used to calculate the level of significance. After Bonferroni\'s multiple adjustment, we attempted to discover significantly different sites (*p *\< \[0.05/(80 × 11)\]). Subsequently, we downloaded significant SNP allele frequencies from the ALlele FREquency Database (<http://alfred.med.yale.edu>, ALFRED) and analyzed the global genetic variation patterns from the HapMap database (Gibbs et al., [2003](#mgg3574-bib-0009){ref-type="ref"}).

2.5. Population genetic structures analysis {#mgg3574-sec-0011}
-------------------------------------------

In view of the genetic structure of human populations, we used Structure 2.3.4 (Pritchard Lab, Stanford University, USA) (<http://pritchardlab.stanford.edu/software/structure_v.2.3.4.html>) to observe the variation of the selected VIP variants. On the basis of the Bayesian clustering algorithm approach, we performed structural analysis to assign the samples within a hypothetical *K* number of populations hypothesized by Pritchard, Stephens, and Donnelly ([2000](#mgg3574-bib-0022){ref-type="ref"}). The MCMC analyses for each structure analysis (*K* = 3--10) was run for 10,000 steps after an initial burn‐in period of 10,000 steps. And we used △*K* to calculate to identify the most likely number of clusters by STRUCTURE HARVESTER (Evanno, Regnaut, & Goudet, [2005](#mgg3574-bib-0006){ref-type="ref"}). Moreover, Wright\'s *F*‐statistics is the most widely used descriptive statistics in population and evolutionary genetics. (Wright, [1931](#mgg3574-bib-0031){ref-type="ref"}). We used the program Arlequin version 3.1 to calculate the Fst values to deduce the pairwise distance between populations. Besides, neighbor‐joining method was used to group them in several clusters based on the genetic distance.

3. RESULTS {#mgg3574-sec-0012}
==========

3.1. Basic information of the VIP variants {#mgg3574-sec-0013}
------------------------------------------

We selected 80 VIP variants from PharmGKB database in 100 members of the Blang population.

The selected single‐nucleotide polymorphisms (SNPs) of PCR primers (listed in Table [S1](#mgg3574-sup-0001){ref-type="supplementary-material"}) were designed by the Sequenom MassARRAY Assay Design 3.0 Software. The basic information of the selected variants has been shown in Table [1](#mgg3574-tbl-0001){ref-type="table"}, including the genes name, their positions, the nucleotide change, the amino acid translation, the allele frequencies, and the genotype frequencies of Blang and the like.

###### 

Basic information of selected VIP variants

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  SNP          Gene      Full name                                                    Chr     Allele   Position     Amino Acid Translation   Function       Allele A          Allele B   Blang   HWE              
  ------------ --------- ------------------------------------------------------------ ------- -------- ------------ ------------------------ -------------- ----------------- ---------- ------- ----- ---- ----- -------
  rs1045642    ABCB1     ATP binding cassette subfamily B member 1                    chr7    A        G            87,138,645               Ile1145Ile     Synonymous        0.335      0.665   12    43   45    0.941

  rs1128503    ABCB1     ATP binding cassette subfamily B member 1                    chr7    A        G            87,179,601               Gly412Gly      Synonymous        0.590      0.410   36    46   18    0.886

  rs2032582    ABCB1     ATP binding cassette subfamily B member 1                    chr7    A        C            87,160,618               Ser893Ala      Missense          0.378      0.622   11    43   32    0.841

  rs975833     ADH1A     alcohol dehydrogenase 1A (class I), alpha polypeptide        chr4    G        C            100,201,739              ---            Intronic          0.365      0.635   11    51   38    0.605

  rs1229984    ADH1B     alcohol dehydrogenase 1B (class I), beta polypeptide         chr4    T        C            100,239,319              His48Arg       Missense          0.035      0.965   0     7    93    0.936

  rs2066702    ADH1B     alcohol dehydrogenase 1B (class I), beta polypeptide         chr4    G        A            100,229,017              Arg370Cys      Missense          1.000      0.000   100   0    0     ---

  rs1801253    ADRB1     adrenoceptor beta 1                                          chr10   G        C            115,805,056              Gly389Arg      Missense          0.350      0.650   14    40   43    0.65

  rs1042713    ADRB2     adrenoceptor beta 2                                          chr5    G        A            148,206,440              Arg16Gly       Missense          0.395      0.605   10    59   31    0.064

  rs1042714    ADRB2     adrenoceptor beta 2                                          chr5    G        C            148,206,473              Gln27Glu       Missense          0.050      0.950   0     10   90    0.87

  rs1800888    ADRB2     adrenoceptor beta 2                                          chr5    C        T            148,206,885              Thr164Ile      Missense          1.000      0.000   100   0    0     ---

  rs2066853    AHR       aryl hydrocarbon receptor                                    chr7    G        A            17,379,110               Arg554Lys      Missense          0.845      0.155   73    23   4     0.475

  rs6151031    ALDH1A1   aldehyde dehydrogenase 1 family member A1                    chr9    ---      CTGGTGAGG\   72,953,467               ---            ---               0.953      0.047   87    9    0     0.89
                                                                                                       AGAGAACC                                                                                                   

  rs1800497    ANKK1     ankyrin repeat and kinase domain containing 1                chr11   G        A            113,270,828              Glu713Lys      Missense          0.720      0.280   54    36   10    0.563

  rs4680       COMT      catechol‐O‐methyltransferase                                 chr22   G        A            19,951,271               Val158Met      Missense          0.860      0.140   72    28   0     0.266

  rs1801272    CYP2A6    cytochrome P450 family 2 subfamily A member 6                chr19   A        T            41,354,533               Leu160His      Missense          0.000      1.000   0     0    100   ---

  rs28399433   CYP2A6    cytochrome P450 family 2 subfamily A member 6                chr19   G        T            41,356,379               ---            ---               0.200      0.800   4     32   64    1

  rs28399444   CYP2A6    cytochrome P450 family 2 subfamily A member 6                chr19   G        A            41,354,190               ---            Frameshift        0.000      1.000   0     0    100   ---

  rs28399454   CYP2A6    cytochrome P450 family 2 subfamily A member 6                chr19   C        T            41,351,267               Val365Met      Missense          1.000      0.000   100   0    0     ---

  rs28399499   CYP2B6    cytochrome P450 family 2 subfamily B member 6                chr19   T        C            41,518,221               Ile328Thr      Missense          1.000      0.000   100   0    0     ---

  rs3745274    CYP2B6    cytochrome P450 family 2 subfamily B member 6                chr19   G        T            41,512,841               Gln172His      Missense          0.485      0.515   21    55   24    0.601

  rs4986893    CYP2C19   cytochrome P450 family 2 subfamily C member 19               chr10   A        G            96,540,410               Trp212null     Stop Codon        0.025      0.975   0     5    95    0.968

  rs1799853    CYP2C9    cytochrome P450 family 2 subfamily C member 9                chr10   C        T            96,702,047               Arg144Cys      Missense          1.000      0.000   100   0    0     ---

  rs16947      CYP2D6    cytochrome P450 family 2 subfamily D member 6                chr22   A        G            42,523,943               Arg296Cys      Missense          0.210      0.790   0     42   58    0.029

  rs28371706   CYP2D6    cytochrome P450 family 2 subfamily D member 6                chr22   G        A            42,525,772               Thr107Ile      Missense          1.000      0.000   100   0    0     ---

  rs28371725   CYP2D6    cytochrome P450 family 2 subfamily D member 6                chr22   A        G            42,523,805               ---            Intronic          0.130      0.870   1     24   75    0.83

  rs5030656    CYP2D6    cytochrome P450 family 2 subfamily D member 6                chr22   ---      AAG          42,128,174               deletes K281   Non‐synonymous    0.000      1.000   0     0    100   ---

  rs59421388   CYP2D6    cytochrome P450 family 2 subfamily D member 6                chr22   C        T            42,523,610               Val338Met      Missense          1.000      0.000   100   0    0     ---

  rs61736512   CYP2D6    cytochrome P450 family 2 subfamily D member 6                chr22   C        T            42,525,134               Val136Met      Missense          1.000      0.000   100   0    0     ---

  rs12721634   CYP3A4    cytochrome P450 family 3 subfamily A member 4                chr7    C        T            99,381,661               Leu15Pro       Missense          0.000      1.000   0     0    100   ---

  rs2740574    CYP3A4    cytochrome P450 family 3 subfamily A member 4                chr7    A        G            99,382,096               ---            ---               1.000      0.000   100   0    0     ---

  rs4986909    CYP3A4    cytochrome P450 family 3 subfamily A member 4                chr7    G        A            99,359,670               Pro415Leu      Missense          1.000      0.000   100   0    0     ---

  rs4986910    CYP3A4    cytochrome P450 family 3 subfamily A member 4                chr7    A        G            99,358,524               Met444Thr      Missense          1.000      0.000   100   0    0     ---

  rs4986913    CYP3A4    cytochrome P450 family 3 subfamily A member 4                chr7    G        A            99,358,459               Pro466Ser      Missense          1.000      0.000   100   0    0     ---

  rs10264272   CYP3A5    cytochrome P450 family 3 subfamily A member 5                chr7    C        T            99,262,835               Lys208Lys      Synonymous        1.000      0.000   100   0    0     ---

  rs3918290    DPYD      dihydropyrimidine dehydrogenase                              chr1    C        T            97,915,614               ---            Splice acceptor   1.000      0.000   100   0    0     ---

  rs6277       DRD2      dopamine receptor D2                                         chr11   G        A            113,283,459              Pro319Pro      Synonymous        0.975      0.025   95    5    0     0.968

  rs1138272    GSTP1     glutathione S‐transferase pi 1                               chr11   C        T            67,353,579               Ala114Val      Missense          1.000      0.000   100   0    0     ---

  rs1695       GSTP1     glutathione S‐transferase pi 1                               chr11   A        G            67,352,689               Ile105Val      Missense          0.740      0.260   55    38   7     0.992

  rs17238540   HMGCR     3‐hydroxy−3‐methylglutaryl‐CoA reductase                     chr5    G        T            74,655,498               ---            Splice acceptor   0.000      1.000   0     0    100   ---

  rs17244841   HMGCR     3‐hydroxy−3‐methylglutaryl‐CoA reductase                     chr5    A        T            74,642,855               ---            Intronic          0.929      0.071   87    8    3     0.001

  rs3846662    HMGCR     3‐hydroxy−3‐methylglutaryl‐CoA reductase                     chr5    A        G            74,651,084               ---            Intronic          0.465      0.535   22    48   29    0.968

  rs12720441   KCNH2     potassium voltage‐gated channel subfamily H member 2         chr7    G        A            150,647,304              Arg784Trp      Missense          1.000      0.000   100   0    0     ---

  rs36210421   KCNH2     potassium voltage‐gated channel subfamily H member 2         chr7    G        T            150,644,428              Arg1047Leu     Missense          1.000      0.000   99    0    0     ---

  rs3807375    KCNH2     potassium voltage‐gated channel subfamily H member 2         chr7    C        T            150,667,210              ---            Intronic          0.200      0.800   6     28   66    0.458

  rs1801131    MTHFR     methylenetetrahydrofolate reductase                          chr1    T        G            11,854,476               Glu429Ala      Missense          0.795      0.205   65    29   6     0.544

  rs1801133    MTHFR     methylenetetrahydrofolate reductase                          chr1    G        A            11,856,378               Ala222Val      Missense          0.770      0.230   62    30   8     0.31

  rs1800566    NQO1      NAD(P)H quinone dehydrogenase 1                              chr16   G        A            69,711,242               Pro187Ser      Missense          0.595      0.405   32    55   13    0.369

  rs3814055    NR1I2     nuclear receptor subfamily 1 group I member 2                chr3    C        T            119,500,035              ---            5\'‐UTR           0.940      0.060   88    12   0     0.816

  rs1065776    P2RY1     purinergic receptor P2Y1                                     chr3    C        T            152,553,628              Ala19Ala       Synonymous        0.875      0.125   64    19   1     0.953

  rs701265     P2RY1     purinergic receptor P2Y1                                     chr3    A        G            152,554,357              Val262Val      Synonymous        0.695      0.305   45    49   6     0.297

  rs2046934    P2RY12    purinergic receptor P2Y12                                    chr3    G        A            151,057,642              ---            Intronic          0.085      0.915   0     17   83    0.65

  rs5629       PTGIS     prostaglandin I2 synthase                                    chr20   G        T            48,129,706               Arg373Arg      Synonymous        0.885      0.115   77    23   0     0.43

  rs689466     PTGS2     prostaglandin‐endoperoxide synthase 2                        chr1    T        C            186,650,751              ---            ---               0.596      0.404   36    46   17    0.941

  rs1805124    SCN5A     sodium voltage‐gated channel alpha subunit 5                 chr3    T        C            38,645,420               His558Arg      Missense          0.890      0.110   81    16   3     0.188

  rs6791924    SCN5A     sodium voltage‐gated channel alpha subunit 5                 chr3    G        A            38,674,699               Arg34Cys       Missense          1.000      0.000   100   0    0     ---

  rs7626962    SCN5A     sodium voltage‐gated channel alpha subunit 5                 chr3    T        G            38,620,907               Ser1103Tyr     Missense          0.000      1.000   0     0    100   ---

  rs1051266    SLC19A1   solute carrier family 19 member 1                            chr21   T        C            46,957,794               His27Arg       Missense          0.436      0.564   13    56   25    0.123

  rs12659      SLC19A1   solute carrier family 19 member 1                            chr21   C        T            46,951,556               Pro232Pro      Synonymous        0.556      0.444   25    59   14    0.094

  rs4149056    SLCO1B1   solute carrier organic anion transporter family member 1B1   chr12   T        C            21,331,549               Val174Ala      Missense          0.965      0.035   93    7    0     0.936

  rs1801030    SULT1A1   sulfotransferase family 1A member 1                          chr16   C        T            28,617,485               Val 223Met     Missense          0.000      1.000   0     0    100   ---

  rs3760091    SULT1A1   sulfotransferase family 1A member 1                          chr16   G        C            28,609,479               ---            Intronic          0.355      0.645   6     59   35    0.016

  rs1142345    TPMT      thiopurine S‐methyltransferase                               chr6    T        C            18,130,918               Tyr240Cys      Missense          0.985      0.015   95    3    0     0.988

  rs1800460    TPMT      thiopurine S‐methyltransferase                               chr6    A        G            18,139,228               Ala154Thr      Missense          0.000      1.000   0     0    100   ---

  rs1800462    TPMT      thiopurine S‐methyltransferase                               chr6    C        G            18,143,955               Ala80Pro       Missense          0.000      1.000   0     0    98    ---

  rs34489327   TS        thymidylate synthetase                                       chr18   Del                                            ---            3\'‐UTR           1.000      0.000   100   0    0     ---

  rs10929302   UGT1A1    UDP glucuronosyltransferase family                           chr2    G        A            234,665,782              ---            Intronic          0.880      0.120   78    20   2     0.869

  rs4124874    UGT1A1    UDP glucuronosyltransferase family 1 member A1               chr2    T        G            234,665,659              ---            Intronic          0.530      0.470   32    42   26    0.292

  rs4148323    UGT1A1    UDP glucuronosyltransferase family 1 member A1               chr2    G        A            234,669,144              Gly71Arg       Missense          0.845      0.155   71    27   2     0.954

  rs10735810   VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   A        G            48,272,895               Met1Thr        Missense          0.571      0.429   28    57   14    0.22

  rs11568820   VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   C        T            48,302,545               ---            ---               0.196      0.804   4     21   49    0.694

  rs1540339    VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   C        T            48,257,326               ---            Intronic          0.340      0.660   13    42   45    0.814

  rs1544410    VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   C        T            48,239,835               ---            Intronic          0.975      0.025   94    5    0     0.967

  rs2228570    VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   T        C            48,272,895               Met1Thr        Missense          0.575      0.425   29    57   14    0.251

  rs2239179    VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   T        C            48,257,766               ---            Intronic          0.000      0.000   0     0    0     ---

  rs2239185    VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   G        A            48,244,559               ---            Intronic          0.695      0.305   43    53   4     0.044

  rs731236     VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   A        G            48,238,757               Ile352Ile      Synonymous        0.975      0.025   95    5    0     0.968

  rs7975232    VDR       vitamin D (1,25‐dihydroxyvitamin D3) receptor                chr12   C        A            48,238,837               ---            Intronic          0.695      0.305   43    53   4     0.044

  rs7294       VKORC1    vitamin K epoxide reductase complex subunit 1                chr16   C        T            31,102,321               ---            3\'‐UTR           0.874      0.126   75    23   1     0.87

  rs9923231    VKORC1    vitamin K epoxide reductase complex subunit 1                chr16   A        C            31,096,368               ---            ---               1.000      0.000   100   0    0     ---

  rs9934438    VKORC1    vitamin K epoxide reductase complex subunit 1                chr16   G        A            31,104,878               ---            Intronic          0.125      0.875   1     23   76    0.876
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SNP: single‐nucleotide polymorphism; HWE: Hardy--Weinberg equilibrium. The GenBank reference of the above genes were as follows: *ABCB1* (NC_000007.14), *ADH1A* (NC_000004.12), *ADH1B*(NC_000004.12), *ADRB1* (NC_000010.11), *ADRB2* (NC_000005.10), *AHR* (NC_000007.14), *ALDH1A1* (NC_000009.12), *ANKK1* (NC_000011.10), *COMT* (NC_000022.11), *CYP2A6* (NC_000019.10), *CYP2B6* (NC_000019.10), *CYP2C19* (NC_000010.11), *CYP2C9* (NC_000010.11), *CYP2D6* (NC_000022.11), *CYP3A4* (NC_000007.14), *CYP3A5* (NC_000007.14), *DPYD* (NC_000001.11), *DRD2* (NC_000011.10), *GSTP1* (NC_000011.10), *HMGCR* (NC_000005.10), *KCNH2* (NC_000007.14), *MTHFR* (NC_000001.11), *NQO1* (NC_000016.10), *NR1I2* (NC_000003.12), *P2RY1* (NC_000003.12), *P2RY12* (NC_000003.12), *PTGIS* (NC_000020.11), *PTGS2* (NC_000001.11), *SCN5A* (NC_000003.12), *SLC19A1* (NC_000021.9), *SLCO1B1* (NC_000012.12), *SULT1A1* (NC_000016.10), *TPMT* (NC_000006.12), *TS* (NC_000018.10), *UGT1A1* (NC_000002.12), *VDR* (NC_000012.12), *VKORC1* (NC_000016.10).
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3.2. Analyses of 80 loci among 12 populations {#mgg3574-sec-0014}
---------------------------------------------

The average variants call rate of the results was over 95%. All selected loci meet the HWE. Using chi‐square test, we compared the Blangs and the 11 populations of the genotype frequencies distribution of 80 loci. Before adjustment (*p* \< 0.05), we found that some loci were different (not shown). When compared to the 11 groups (ASW, CEU, CHB, CHD, GIH, JPT, LWK, MEX, MKK, TSI, and YRI) and Blang without adjustment, the number of significantly different variants in the Blang population was 23, 30, 17, 30, 30, 21, 26, 21, 25, 22, and 35, respectively (data no shown). After adjustment (*p* \< \[0.05/(80 × 11)\], listed in Table [2](#mgg3574-tbl-0002){ref-type="table"}), there were 15, 20, 6, 25, 25, 7, 19, 7, 20, 15, and 26 loci of significant differences between Blang and the 11 populations, respectively. While there were contrasts in the two sets of data, there were also similarities. It was also noteworthy that the different loci between CHB and the Blang were the least.

###### 

Significant VIP variants in the Blangs compared with the 11 populations after Bonferroni\'s multiple adjustment

  SNP ID       Gene      *p* \< 0.05/（80\*11）                                                                                                                                                     
  ------------ --------- ------------------------ --------------- ---------------- --------------- --------------- --------------- --------------- --------------- ---------------- --------------- ---------------
  rs1045642    ABCB1     0.059                    **2.873E−06**   0.277            0.024           0.292           0.022           ---             0.076           **2.808E−05**    0.042           **4.723E−07**
  rs1128503    ABCB1     **2.072E−09**            0.005           0.072            ---             **2.890E−10**   0.974           **2.319E−17**   0.070           **5.876E−19**    0.009           **7.463E−19**
  rs2032582    ABCB1     **1.486E−06**            0.161           0.001            ---             ---             0.003           **5.000E−16**   0.668           **2.232E−12**    0.465           ---
  rs975833     ADH1A     ---                      **3.544E−08**   0.001            ---             ---             0.011           ---             ---             ---              ---             **9.068E−09**
  rs1229984    ADH1B     ---                      ---             **3.393E−25**    ---             ---             **9.317E−25**   ---             ---             ---              ---             ---
  rs2066702    ADH1B     **1.065E−10**            ---             ---              **1.056E−19**   **2.444E−05**   ---             **4.081E−07**   ---             ---              ---             **5.646E−15**
  rs1801253    ADRB1     ---                      0.785           0.217            ---             ---             0.004           ---             ---             ---              ---             0.365
  rs1042713    ADRB2     0.258                    **4.559E−07**   0.481            ---             ---             0.001           0.028           0.011           0.097            **1.166E−07**   0.003
  rs1042714    ADRB2     ---                      **1.530E−12**   ---              **8.438E−14**   **9.243E−23**   0.305           ---             ---             ---              ---             0.002
  rs1800888    ADRB2     ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs2066853    AHR       **1.696E−05**            0.181           **1.202 E−06**   ---             ---             **5.580E−09**   **1.516E−10**   0.358           **2.034E−06**    0.085           **5.504E−09**
  rs6151031    ALDH1A1   ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs1800497    ANKK1     0.107                    0.144           0.025            0.000           0.077           0.031           0.129           0.024           0.115            0.261           0.012
  rs4680       COMT      0.002                    **2.205E−11**   0.000            ---             ---             0.001           0.000           **2.862E−06**   0.001            **2.593E−10**   0.000
  rs1801272    CYP2A6    ---                      **1.805E−35**   ---              **6.726E−41**   **7.698E−40**   **5.380E−32**   ---             ---             ---              ---             ---
  rs28399433   CYP2A6    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs28399444   CYP2A6    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs28399454   CYP2A6    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs28399499   CYP2B6    0.000                    ---             ---              ---             ---             ---             ---             ---             0.168            ---             **2.037E−06**
  rs3745274    CYP2B6    0.000                    **1.314E−06**   **1.166E−10**    ---             ---             **2.002E−10**   0.000           0.001           0.007            **2.326E−05**   0.100
  rs4986893    CYP2C19   ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs1799853    CYP2C9    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs16947      CYP2D6    ---                      ---             ---              0.248           0.003           ---             ---             ---             ---              ---             ---
  rs28371706   CYP2D6    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs28371725   CYP2D6    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs5030656    CYP2D6    ---                      ---             ---              **2.373E−13**   **7.203E−13**   ---             ---             ---             ---              ---             ---
  rs59421388   CYP2D6    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs61736512   CYP2D6    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs12721634   CYP3A4    ---                      ---             ---              **9.801E−37**   **3.439E−16**   ---             ---             ---             ---              ---             ---
  rs2740574    CYP3A4    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs4986909    CYP3A4    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs4986910    CYP3A4    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs4986913    CYP3A4    ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs10264272   CYP3A5    ---                      ---             ---              **7.700E−31**   **2.008E−21**   ---             **1.445E−12**   ---             **8.823E−08**    ---             **8.948E−09**
  rs3918290    DPYD      ---                      ---             ---              **3.132E−18**   **1.273E−33**   ---             ---             ---             ---              ---             ---
  rs6277       DRD2      ---                      **1.663E−22**   ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs1138272    GSTP1     ---                      ---             ---              ---             ---             ---             ---             0.001           ---              ---             ---
  rs1695       GSTP1     0.003                    0.003           0.231            ---             ---             0.000           **1.935E−06**   **1.304E−05**   0.079            0.514           0.014
  rs17238540   HMGCR     ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs17244841   HMGCR     ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs3846662    HMGCR     **1.111E−07**            0.084           0.994            ---             **1.222E−23**   0.607           **3.482E−18**   0.030           **2.452E−11**    0.257           **8.429E−20**
  rs12720441   KCNH2     ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs36210421   KCNH2     ---                      ---             ---              **2.249E−07**   **2.963E−20**   ---             ---             ---             ---              ---             ---
  rs3807375    KCNH2     0.042                    **5.814E−16**   0.172            **3.093E−18**   **1.580E−11**   0.165           0.619           0.001           0.048231         **1.349E−15**   0.627
  rs1801131    MTHFR     0.458                    0.006           0.439            0.013           0.448           0.440           0.688           0.753           0.308            0.066           0.035
  rs1801133    MTHFR     0.013                    0.076           **1.559E−05**    ---             ---             0.009           0.002           0.002           0.000            0.000           0.001
  rs1800566    NQO1      0.001                    **2.084E−06**   0.135            ---             ---             0.403           **3.384E−06**   0.218           **3.058E−08**    0.000           **4.510E−06**
  rs3814055    NR1I2     **1.029E−07**            **9.604E−11**   **2.269E−07**    **1.593E−19**   **1.270E−25**   **1.087E−06**   **1.235E−07**   **1.475E−07**   **3.575E−06**    **8.035E−13**   **1.283E−07**
  rs1065776    P2RY1     ---                      ---             ---              **2.296E−11**   **2.388E−19**   ---             ---             ---             ---              ---             ---
  rs701265     P2RY1     **1.620E−09**            0.007           0.293            **5.222E−08**   **3.034E−13**   0.266           **6.247E−19**   0.052           **8.827E−19**    0.001           **1.022E−20**
  rs2046934    P2RY12    ---                      0.001           0.010            ---             ---             0.020           ---             ---             ---              ---             0.004
  rs5629       PTGIS     0.124                    0.006           0.003            ---             ---             0.008           ---             0.001           0.701            **9.651E−07**   0.408
  rs689466     PTGS2     **1.039E−06**            **1.169E−06**   0.175            0.007           0.001           0.339           **4.422E−15**   0.029           **5.0037E−21**   **1.203E−05**   **1.306E−11**
  rs1805124    SCN5A     0.003                    0.008           0.194            **1.046E−15**   **1.110E−07**   0.082           0.000           0.334           **2.198E−08**    0.004           **1.258E−06**
  rs6791924    SCN5A     ---                      ---             ---              **2.606E−22**   **1.626E−07**   ---             ---             ---             ---              ---             ---
  rs7626962    SCN5A     ---                      ---             ---              **4.880E−15**   **7.055E−29**   ---             ---             ---             ---              ---             0.001
  rs1051266    SLC19A1   0.531                    0.818           0.056            ---             ---             0.018           **8.244E−09**   0.059           **9.767E−13**    0.181           **1.011E−07**
  rs12659      SLC19A1   ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs4149056    SLCO1B1   0.382                    0.000           0.000            **4.768E−12**   **3.391E−15**   0.024           ---             ---             0.007            **4.259E−07**   ---
  rs1801030    SULT1A1   ---                      ---             ---              **5.982E−36**   **3.565E−30**   ---             ---             ---             ---              ---             ---
  rs3760091    SULT1A1   ---                      ---             ---              **1.349E−12**   0.255           ---             ---             ---             ---              ---             ---
  rs1142345    TPMT      ---                      ---             ---              **1.031E−15**   **8.286E−19**   ---             0.001           0.034           ---              ---             0.269
  rs1800460    TPMT      ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs1800462    TPMT      ---                      ---             ---              **2.714E−22**   **1.166E−12**   ---             ---             ---             ---              ---             ---
  rs34489327   TS        ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs10929302   UGT1A1    ---                      0.002           0.592            **2.608E−05**   **4.574E−09**   0.610           ---             ---             ---              ---             **1.298E−05**
  rs4124874    UGT1A1    **8.170E−06**            0.630           0.0002           **2.226E−07**   **3.725E−18**   0.029           **1.136E−13**   0.832           **1.947E−13**    0.277           **1.265E−17**
  rs4148323    UGT1A1    ---                      **2.428E−05**   0.108            0.536           0.000           0.769           ---             0.007           ---              ---             **2.428E−05**
  rs10735810   VDR       **1.259E−10**            0.001           0.003            ---             ---             **4.321E−07**   **1.916E−15**   0.299           **3.465E−15**    0.000           **2.414E−14**
  rs11568820   VDR       0.133                    **2.969E−22**   **4.962E−08**    ---             ---             **1.086E−07**   0.061           **8.376E−15**   0.618            **7.171E−18**   **5.433E−07**
  rs1540339    VDR       **1.172E−09**            **1.135E−07**   0.520            **6.552E−26**   **1.452E−05**   0.284           **4.490E−19**   0.000           **2.537E−20**    **1.931E−07**   **1.484E−16**
  rs1544410    VDR       ---                      **9.321E−19**   ---              ---             ---             ---             **1.521E−09**   **3.563E−08**   **1.478E−16**    **2.207E−17**   **1.580E−11**
  rs2228570    VDR       ---                      ---             ---              **1.814E−11**   0.110           ---             ---             ---             ---              ---             ---
  rs2239179    VDR       ---                      ---             ---              ---             ---             ---             ---             ---             ---              ---             ---
  rs2239185    VDR       ---                      ---             0.027            ---             ---             0.161           ---             ---             ---              ---             **8.001E−06**
  rs731236     VDR       **3.289E−08**            **6.439E−19**   ---              ---             ---             ---             **1.059E−09**   **7.603E−09**   **4.993E−24**    **1.560E−17**   **1.221E−12**
  rs7975232    VDR       **1.511E−08**            **1.887E−08**   0.040            ---             ---             0.127           **1.767E−15**   0.016           **1.807E−14**    **1.129E−08**   **9.107E−11**
  rs7294       VKORC1    **4.496E−11**            **2.436E−07**   0.051            0.014           0.000           0.553           **1.328E−10**   0.000           **3.526E−14**    **4.204E−06**   **9.144E−15**
  rs9923231    VKORC1    ---                      ---             ---              **1.109E−40**   **1.328E−10**   ---             ---             ---             ---              ---             ---
  rs9934438    VKORC1    **1.112E−25**            **6.971E−18**   0.055            ---             ---             0.551           **1.212E−34**   **1.623E−11**   **6.354E−37**    **9.903E−14**   **1.557E−42**

SNP: single‐nucleotide polymorphism; HWE: Hardy--Weinberg equilibrium. ASW, a population of African ancestry in the southwestern USA; CEU, a residents population in Utah with Northern and Western European Ancestry; CHB, the Chinese Han in Beijing, China; CHD, the population of metropolitan Denver, Colorado, USA; GIH, the Gujarati Indians in Houston, Texas, USA; JPT, the Japanese population in Tokyo, Japan; LWK, the Chinese living in Luhya in Webuye, Kenya; MEX, people with Mexican ancestry living in Los Angeles, California, USA; MKK, the Maasai people in Kinyawa, Kenya; TSI, the Tuscan people of Italy; YRI, the Yoruba in Ibadan, Nigeria. The GenBank reference of the above genes were as follows: *ABCB1* (NC_000007.14), *ADH1A* (NC_000004.12), *ADH1B*(NC_000004.12), *ADRB1* (NC_000010.11), *ADRB2* (NC_000005.10), *AHR* (NC_000007.14), *ALDH1A1* (NC_000009.12), *ANKK1* (NC_000011.10), *COMT* (NC_000022.11), *CYP2A6* (NC_000019.10), *CYP2B6* (NC_000019.10), *CYP2C19* (NC_000010.11), *CYP2C9* (NC_000010.11), *CYP2D6* (NC_000022.11), *CYP3A4* (NC_000007.14), *CYP3A5* (NC_000007.14), *DPYD* (NC_000001.11), *DRD2* (NC_000011.10), *GSTP1* (NC_000011.10), *HMGCR* (NC_000005.10), *KCNH2* (NC_000007.14), *MTHFR* (NC_000001.11), *NQO1* (NC_000016.10), *NR1I2* (NC_000003.12), *P2RY1* (NC_000003.12), *P2RY12* (NC_000003.12), *PTGIS* (NC_000020.11), *PTGS2* (NC_000001.11), *SCN5A* (NC_000003.12), *SLC19A1* (NC_000021.9), *SLCO1B1* (NC_000012.12), *SULT1A1* (NC_000016.10), *TPMT* (NC_000006.12), *TS* (NC_000018.10), *UGT1A1* (NC_000002.12), *VDR* (NC_000012.12), *VKORC1* (NC_000016.10).

Bold type indicates that the locus has statistically significant.
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However, through a comparison of before and after adjustment, the distribution of rs1801133 (HGVS: NM_001330358.1:c.788C\>T) and rs4680 (HGVS: NM_000754.3:c.472G\>A) in populations has changed. After correction for multiple tests, rs1801133 became less significant in ASW, JPT, LWK, MEX, MKK, TSI, YRI, except CHB. Besides, rs4680 were detected significant differences between CEU, MEX, TSI, and Blang. In the populations of ASW, CHB, JPT, LWK, MKK, and YRI, its differences disappeared. Nonetheless, some variants varied little, not even a bit, such as rs11568820, rs1544410, and so forth.

After analysis of Table [2](#mgg3574-tbl-0002){ref-type="table"}, significant variants in some genes were distributed in every population, such as *VDR* and *NR1I2*. There were rs10735810, rs11568820, rs1540339, rs1544410, rs2228570, rs2239179, rs2239185, rs731236, and rs7975232 distributed in *VDR*(*vitamin D receptor*), which encodes the nuclear hormone receptor for vitamin D3. Although failing to make amino acid changed, rs1540339 was also very significant among the nine populations except CHB, JPT, and MEX. Although rs2228570 (HGVS: NM_000376.2:c.2 T\>G) was, the only one SNP changing amino acid, located in exon 2 of *VDR*, it was still prominent in the CHD.

Although rs3814055 in *NR1I2*changed little, significant differences still existed. We downloaded the associated data of rs3814055 from the website (<http://alfred.med.yale.edu>). As seen from the Figures [1](#mgg3574-fig-0001){ref-type="fig"} and [2](#mgg3574-fig-0002){ref-type="fig"}, the frequency of the Blangs was closer to the populations distributed in East Asia, especially Miao. On the whole, the frequencies of the allele C of rs3814055, ranged from 67% to 94%, were higher in East Asia than the other populations. The Blang population was the highest among them, so attention should be paid to its allele C.

![The frequencies of rs3814055 in the different populations. NA, North America; SA, South America; S, Siberia; O, Oceania](MGG3-7-e574-g001){#mgg3574-fig-0001}

![Rs3814055 frequencies in different populations of the world. NA, North America; SA, South America; S, Siberia; O, Oceania](MGG3-7-e574-g002){#mgg3574-fig-0002}

3.3. The relationship between 23 populations {#mgg3574-sec-0015}
--------------------------------------------

We used Structure 2.3.1 Software to analyze the genetic structure of the 23 populations in order to further identify the relationships between them throughout the world. Different *K* values ranging from 2 to 10 were hypothetically in structure analysis. And, the results of *K* = 2,3 among global populations and the results of *K* = 3,4 ethnic groups from China were shown in Figure [3](#mgg3574-fig-0003){ref-type="fig"}. The cluster analysis indicated that when *K* = 3, the group was divided into three subgroups (subgroups 1: Blang, CHB, CHD, JPT, SX Han; subgroups 2: CEU, GIH, MEX, TSI, Deng, Sherpa, Lhoba, Kyrgyz, Tajik, Uygur; subgroups 3: ASW, LWK, MKK, YRI, Miao, Li, Tibet, Mongol) based on relative majority of likelihood to assign individuals to subgroups. The results illustrated that Blang had a relatively closer affinity with CHB, CHD, and JPT. In accordance with the Table [2](#mgg3574-tbl-0002){ref-type="table"}, the results were confirmed. Likewise, when comparing ethnic groups within China, we found that Blang was closer to SX Han.

![Analysis the genetic structure between Blang and the 23 populations. *K* denotes the possible numbers of parental population clusters. Each vertical bar represents a person, dividing into color sections. *K* = 2, 3 were used to assess the genetic relationship between Blang and 11 global populations. And the genetic relationship between 11 ethnic groups from China and Blang were evaluated by *K* = 3, 4. ASW: ASW: a population of African ancestry in southwestern USA; CEU: a residents population in Utah with Northern and Western European Ancestry; CHB: the Chinese Han in Beijing, China; CHD: Chinese in Metropolitan Denver, Colorado, USA; GIH: Gujarati Indians in Houston, Texas, USA; JPT: Japanese in Tokyo, Japan; LWK: Luhya people in Webuye, Kenya; MEX: people with Mexican ancestry in Los Angeles, California, USA; MKK: Maasai people in Kinyawa, Kenya; TSI: Toscans in Italy; YRI: Yoruba in Ibadan, Nigeria; SX Han, Shaanxi Han. A: Comparing the Blangs with the other 11 populations from the International HapMap Project, Blang was closer to CHB, CHD, and JPT. B: The Han nationality in Shaanxi was very close to the Blangs within China](MGG3-7-e574-g003){#mgg3574-fig-0003}

![The phylogenetic tree was reconstructed by the neighboring‐joining method among 12 populations](MGG3-7-e574-g004){#mgg3574-fig-0004}

Based on genetic structure, we further assessed the genetic relationship among 12 populations by using pairwise Fst values (Table [3](#mgg3574-tbl-0003){ref-type="table"}). As mentioned in it, it was clear that the differences between CHB, CHD, JPT, and Blang (Fst = 0.04728, 0.04259, and 0.04914, respectively) were smaller. The smaller the Fst value, the more similar they were. The results indicated that the Blang and the other three groups had a relatively closer affinity, followed by MEX. As presented by the phylogenetic tree (Figure [4](#mgg3574-fig-0004){ref-type="fig"}) about 12 populations in the same Fst‐based way, the results were verified again.

###### 

Fst values among 12 populations

        BuL           CHB        CHD       JPT       CEU       GIH       MEX       TSI       ASW       LWK       MKK       YRI
  ----- ------------- ---------- --------- --------- --------- --------- --------- --------- --------- --------- --------- -----
  BuL   0                                                                                                                  
  CHB   **0.04728**   0                                                                                                    
  CHD   **0.04259**   −0.00161   0                                                                                         
  JPT   **0.04914**   0.00586    0.00761   0                                                                               
  CEU   0.14462       0.13026    0.12708   0.11499   0                                                                     
  GIH   0.15465       0.15697    0.15321   0.14338   0.03311   0                                                           
  MEX   **0.09721**   0.08424    0.07821   0.08033   0.02248   0.05258   0                                                 
  TSI   0.14058       0.11524    0.11626   0.10172   0.00012   0.04047   0.02447   0                                       
  ASW   0.17273       0.1955     0.19394   0.17125   0.12124   0.08173   0.11144   0.12461   0                             
  LWK   0.23967       0.26654    0.26764   0.23703   0.18539   0.14618   0.18563   0.19061   0.01719   0                   
  MKK   0.20378       0.23189    0.23406   0.19985   0.13638   0.10553   0.15181   0.14253   0.01888   0.01336   0         
  YRI   0.23439       0.26827    0.27045   0.23703   0.19138   0.14351   0.19235   0.1978    0.01513   0.00383   0.01359   0

ASW, a population of African ancestry in the southwestern USA; CEU, a residents population in Utah with Northern and Western European Ancestry; CHB, the Chinese Han in Beijing, China; CHD, the population of metropolitan Denver, Colorado, USA; GIH, the Gujarati Indians in Houston, Texas, USA; JPT, the Japanese population in Tokyo, Japan; LWK, the Chinese living in Luhya in Webuye, Kenya; MEX, people with Mexican ancestry living in Los Angeles, California, USA; MKK, the Maasai people in Kinyawa, Kenya; TSI, the Tuscan people of Italy; YRI, the Yoruba in Ibadan, Nigeria.

John Wiley & Sons, Ltd

4. DISCUSSION {#mgg3574-sec-0016}
=============

There is increasing interested in personalized medicine, because of genetic variations leading to each person\'s different metabolism of and reactions to some drugs. In our results, we genotyped the pharmacogenomic VIP variants in the Blang population. The conclusion was that that *NR1I2*rs3814055 was the most significant variant among the 12 selected populations, followed by *VDR* rs1540339. Using genetic structure analysis and Fst values, we also concluded that the genetic backgrounds of the Blang were similar to CHB.

Pregnane X, encoded by the gene *NR1I2*, belongs to the nuclear hormone receptor superfamily, whose major role is to promote the detoxification and clearance of drugs and toxic xenobiotics from the body as a transcription factor (Bertilsson et al., [1998](#mgg3574-bib-0001){ref-type="ref"}). And some CYPs (Ding et al., [2015](#mgg3574-bib-0003){ref-type="ref"}; Jin, Zhang, Shi et al., [2016a](#mgg3574-bib-0016){ref-type="ref"}; Jin, Zhang, Geng et al., [2016b](#mgg3574-bib-0014){ref-type="ref"}; Shan et al., [2016](#mgg3574-bib-0023){ref-type="ref"}; Zhang et al., [2016](#mgg3574-bib-0034){ref-type="ref"}) regulated by PXR/NR1I2 were associated with phase I metabolism in human. Moreover, some studies (Lown et al., [1997](#mgg3574-bib-0019){ref-type="ref"}; Shimada, Yamazaki, Mimura, Inui, & Guengerich, [1994](#mgg3574-bib-0024){ref-type="ref"}) illustrated that SNPs in PXR may be a main reason to the differences in drug reactions and the induction of CYP3A4. Rs3814055, localized in the 5' untranslated region (UTR) of *NR1I2*, has already attracted the attention of many researchers, for both disease risk and pharmacogenomics impact. Numerous studies showed that the frequency of rs3814055 in the *NR1I2* gene varied according to different populations. The frequency of this variation in a Chinese Han population was 0.218 (Wang et al., [2007](#mgg3574-bib-0030){ref-type="ref"}), 0.39 for Caucasians (Zhang et al., [2013](#mgg3574-bib-0036){ref-type="ref"}), 0.21 for Asians (King et al., [2007](#mgg3574-bib-0017){ref-type="ref"}), 0.50 for Europeans (King et al., [2007](#mgg3574-bib-0017){ref-type="ref"}), 0.36 for the Dutch (Bosch et al., [2006](#mgg3574-bib-0002){ref-type="ref"}), and 0.34 for African Americans (Thomas et al., [2007](#mgg3574-bib-0025){ref-type="ref"}). In our previous studies, the frequency of the rs3814055 SNP variant in the Lhoba population and in the Miao population were 0.101 and 0.09 (He et al., [2015](#mgg3574-bib-0010){ref-type="ref"}; Jin, Aikemu et al., [2015a](#mgg3574-bib-0013){ref-type="ref"}), respectively. In our study about the Blangs, the allele T frequency of rs3814055 was 0.06 (Figures [1](#mgg3574-fig-0001){ref-type="fig"} and [2](#mgg3574-fig-0002){ref-type="fig"}). In a Chinese Han Population, upregulated CYP3A4 expression was due to the frequency of rs3814055 (−25,385 T) (Zhang et al., [2001](#mgg3574-bib-0035){ref-type="ref"}), demonstrating that it was similar to that of Lhoba and Miao. Yet it was still lower than the other populations. Additionally, another report has shown that the allele C linked to Inflammatory Bowel Diseases (IBD) in a European population (Martínez et al., [2010](#mgg3574-bib-0020){ref-type="ref"}). However, the haplotype TCC of rs3814055/rs6784598/rs2276707 functioned as a whole in risk assessment for ulcerative colitis (UC) in Spanish population. In addition, Kurzawski M et al revealed that there were significant differences in tacrolimus concentrations between patients with different NR1I2 rs3814055: C \> T genotypes (Kurzawski, Malinowski, Dziewanowski, & Drozdzik, [2017](#mgg3574-bib-0018){ref-type="ref"}). And Zazuli et al. ([2015](#mgg3574-bib-0033){ref-type="ref"}) found that, in Indonesian patients with tuberculosis, the TT genotype of rs3814055 had a significantly greater risk of antituberculosis drug‐induced liver injury than those of CC genotype.

The SNP rs1540339 is situated in the intron region of VDR. Previous studies have demonstrated that rs1540339 was related to the susceptibility of type 1 diabetes mellitus (T1DM) (Wang et al., [2014](#mgg3574-bib-0028){ref-type="ref"}), colorectal cancer (Wang, Li, & Zhou[2008b](#mgg3574-bib-0027){ref-type="ref"}), and so on. The other study drew the same conclusion that the variant involved in T1DM prevention (Wang, Li et al., [2008b](#mgg3574-bib-0027){ref-type="ref"}). Jin TB et al. reported that the frequency of rs1540339 T in the Li population was higher than the allele C, indicating that the Li group had lower sensitivity to T1DM. In our study, the allele frequencies of rs1540339 C/T in the Blang were 34% and 66%, respectively. So we guess that the Blang may have lower susceptibility to T1DM.

Considering the above results, ethnicity is an important factor for the frequency distribution and the genotype of rs3814055 can be used as a marker for detecting IBD and UC. And the Blang may have a lower susceptibility to T1DM. Although rs1540339 has not been found to be relevant in the Blang, it is noteworthy in future studies. At present, there are more teams, including Jin TB et al., devoted to disease research of SNPs (Du et al., [2016](#mgg3574-bib-0004){ref-type="ref"}; Duan et al., [2015](#mgg3574-bib-0005){ref-type="ref"}; Hu et al., [2014](#mgg3574-bib-0011){ref-type="ref"}; Wang et al., [2015](#mgg3574-bib-0029){ref-type="ref"}; Yang et al., [2016](#mgg3574-bib-0032){ref-type="ref"}), and we hope that our data will complement the pharmacogenomics database and provide some help for the development of personalized medicine.
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